Another study showed that SHP2 expression is also repressed in human esophageal squamous cell cancer (ESCC), and SHP2 knockdown results in increased ESCC cell proliferation in vitro and in vivo, which corresponded with a significant increase in phosphorylated STAT3 [98]. The gene discussed is PTPN11; the disease is esophageal squamous cell carcinoma.